You have 9 free searches left this month | for more free features.

abound.2L

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial in Worldwide (nab-paclitaxel IV, CC-486, Duravalumab)

Active, not recruiting
  • Carcinoma, Non-Small-Cell Lung
  • nab-paclitaxel IV
  • +2 more
  • San Francisco, California
  • +33 more
Jan 24, 2022

Locally Advanced Hepatocellular Carcinoma, Recurrent Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial (RP3,

Not yet recruiting
  • Locally Advanced Hepatocellular Carcinoma
  • +2 more
  • RP3
  • +2 more
  • (no location specified)
Feb 8, 2023

Colonic Disease, Intestinal Disease Trial (OST, 2L-PEG/Asc)

Not yet recruiting
  • Colonic Disease
  • Intestinal Disease
  • (no location specified)
Feb 9, 2022

Colorectal Cancer, Colonic Polyp Trial in Nijmegen (Plenvu, Moviprep)

Recruiting
  • Colorectal Cancer
  • Colonic Polyp
  • Nijmegen, Gelderland, Netherlands
    Radboud university medical center
Aug 8, 2022

Esophageal Squamous Cell Carcinoma Trial (Paclitaxel, Irinotecan, Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Chuo-ku, Tokyo, Japan
    National Cancer Center Hospital ( Site 3700)
Jan 31, 2023

Cabozantinib Post First-line Immuno-oncology Checkpoint

Completed
  • Advanced Renal Cell Carcinoma (aRCC)
    • Glasgow, United Kingdom
    • +8 more
    Jun 30, 2022

    1L-PEG-Asc Solution for Bowel Preparation in"Open Access"

    Completed
    • Bowel Preparation
    • use of a very low-volume 1L-PEG plus ascorbate (plenvu) or low-volume 2L-PEG plus ascorbate (moviprep) for bowel preparation in open access colonoscopy
    • Carpi, Modena, Italy
      Azienda USL Modena
    Feb 15, 2022

    Serplulimab in 2L and Above Treatment of Cervical Cancer

    Recruiting
    • Cervical Cancer
    • Jinan, Shandong, China
      Qilu Hospital of Shandong University
    May 30, 2023

    Type 2 Diabetes Trial in Lubbock (L-citrulline, Placebo)

    Recruiting
    • Type 2 Diabetes
    • L-citrulline
    • Placebo
    • Lubbock, Texas
      TTU Kinesiology and Sport Management Building
    Aug 24, 2023

    Healthy Trial in Seoul (L04RD1, L04TD2)

    Completed
    • Healthy
    • Seoul, Korea, Republic of
      Jaewoo Kim
    Jan 10, 2023

    Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

    Not yet recruiting
    • Advanced Solid Tumor
    • Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Oct 9, 2023

    HER-2 Positive Advanced Solid Tumors Trial (D3L-001)

    Not yet recruiting
    • HER-2 Positive Advanced Solid Tumors
    • D3L-001
    • (no location specified)
    Jul 20, 2023

    NSCLC Trial in Guangzhou (Savolitinib, Docetaxel)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • Guangzhou, Guangdong, China
      Department of Thoracic Surgery and Oncology, The First Affiliate
    Mar 17, 2023

    Diabetic Peripheral Neuropathic Pain Trial in Luoyang (HSK16149 20mg BID)

    Recruiting
    • Diabetic Peripheral Neuropathic Pain
    • HSK16149 20mg BID
    • Luoyang, Henan, China
      The First Affiliated Hospital of Henan University of Science and
    Nov 2, 2023

    Heart Failure Trial in Hamilton (Virtual HF Care, Routine HF Care)

    Recruiting
    • Heart Failure
    • Virtual HF Care
    • Routine HF Care
    • Hamilton, Onatrio, Canada
    • +2 more
    Feb 1, 2023

    Nerve Injury Trial in Hamilton (Temporary Peripheral Nerve Stimulator)

    Recruiting
    • Nerve Injury
    • Temporary Peripheral Nerve Stimulator
    • Hamilton, Ontario, Canada
    • +2 more
    Feb 1, 2023

    Metastatic Microsatellite-stable Colorectal Cancer Trial (LB-100, Atezolizumab)

    Not yet recruiting
    • Metastatic Microsatellite-stable Colorectal Cancer
    • (no location specified)
    Sep 1, 2023

    Anastomotic Leak Trial in Hamilton (Stream™ Platform, Stream™ Platform with Risk Score Omitted)

    Not yet recruiting
    • Anastomotic Leak
    • Stream™ Platform
    • Stream™ Platform with Risk Score Omitted
    • Hamilton, Ontario, Canada
    • +1 more
    Aug 8, 2023

    Fracture, Frailty, Aging Trial in Saint John (Patient Navigation)

    Recruiting
    • Fracture
    • +2 more
    • Patient Navigation
    • Saint John, New Brunswick, Canada
      Saint John Regional Hospital
    Oct 25, 2023

    B-cell Non-Hodgkin Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Mosunetuzumab (SC), Polatuzumab vedotin)

    Recruiting
    • B-cell Non-Hodgkin Lymphoma
    • Mosunetuzumab (IV)
    • +4 more
    • Birmingham, Alabama
    • +28 more
    Jan 6, 2023

    Lung Cancer, Colorectal Cancer Trial in Beijing (18F-FDG)

    Recruiting
    • Lung Cancer
    • Colorectal Cancer
    • Beijing, China
      Beijing Cancer Hospital
    Mar 27, 2023

    Solid Tumor Trial (BS006 Injection)

    Not yet recruiting
    • Solid Tumor
    • BS006 Injection
    • (no location specified)
    Jul 3, 2023

    Metastatic Gastric Cancer, PD-L1 Gene Amplification, FGFR2 Amplification Trial in New York (Nivolumab, Capecitabine,

    Recruiting
    • Metastatic Gastric Cancer
    • +2 more
    • New York, New York
      Bureau for Cancer Research
    May 10, 2023

    Non Small Cell Lung Cancer, ERBB2 Mutation-Related Tumors, RC48 Trial in Guanzhou (RC48+Tislelizumab+carboplatin,

    Not yet recruiting
    • Non Small Cell Lung Cancer
    • +3 more
    • Guanzhou, China
      SunYat-senU
    May 5, 2023

    Glioblastoma Trial (Bevacizumab, PD-L1 t-haNK, N-803)

    Not yet recruiting
    • Glioblastoma
    • (no location specified)
    Sep 25, 2023